{"doi":"10.1016/j.tem.2005.01.003","title":"Antagonists of activin signaling: mechanisms and potential biological applications","abstract":null,"journal":"Trends in Endocrinology & Metabolism","year":2005,"id":28547,"datarank":9.247645899327718,"base_score":5.342334251964811,"endowment":5.342334251964811,"self_citation_contribution":0.8013501377947218,"citation_network_contribution":8.446295761532996,"self_endowment_contribution":0.8013501377947218,"citer_contribution":8.446295761532996,"corpus_percentile":null,"corpus_rank":null,"citation_count":208,"citer_count":182,"citers_with_citation_signal":165,"citers_with_endowment":165,"datacite_reuse_total":8,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":159599,"name":"Peter C. Gray","orcid":null,"position":1,"is_corresponding":false},{"id":156417,"name":"Wylie W. Vale","orcid":null,"position":2,"is_corresponding":false},{"id":159600,"name":"David M. Robertson","orcid":null,"position":3,"is_corresponding":false},{"id":159598,"name":"Craig A. Harrison","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.342334251964811,"endowment":5.342334251964811,"datacite_reuse_total":8,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"15734148","pmcid":null,"openalex_id":"https://openalex.org/W1995609823","authors":[],"funders":[],"total_grants":0,"fwci":6.823,"citation_percentile":0.97743142,"influential_citations":11,"citation_trend":[{"year":2012,"count":20},{"year":2013,"count":11},{"year":2014,"count":9},{"year":2015,"count":8},{"year":2016,"count":8},{"year":2017,"count":8},{"year":2018,"count":4},{"year":2019,"count":3},{"year":2020,"count":5},{"year":2021,"count":17},{"year":2022,"count":2},{"year":2023,"count":3},{"year":2024,"count":5},{"year":2025,"count":2}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S1043276005000044?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1043276005000044?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.tem.2005.01.003","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/15734148","host_type":"repository"}],"fields_of_study":["TGF-β signaling in diseases","Heterotopic Ossification and Related Conditions","Kruppel-like factors research","Biology","Medicine","Activins","Animals","Cachexia","Hormone Antagonists","Humans","Neoplasms","Signal Transduction","Wound Healing"],"mesh_terms":["Animals","Cachexia","Hormone Antagonists","Humans","Neoplasms","Wound Healing","Signal Transduction","Activins"],"keywords":["Follistatin","Activin type 2 receptors","Activin receptor","ACVR2B","Biology","TGF beta signaling pathway","Transforming growth factor","Signal transduction","Receptor","Endocrinology","Internal medicine","Cell biology","Cancer research","Medicine","Biochemistry"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.14608478.v1","title":"Additional file 1 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608478","title":"Additional file 1 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608481.v1","title":"Additional file 2 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608481","title":"Additional file 2 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608484.v1","title":"Additional file 3 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608484","title":"Additional file 3 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608487.v1","title":"Additional file 4 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14608487","title":"Additional file 4 of Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T21:41:59.206619Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}